News | November 23, 2011

Surgical Bypass Strongly Beats Endovascular Treatment as Preferred Treatment of Blocked Blood Vessels in the Femoral Artery

November 23, 2011 – Vascular occlusions are blocked blood vessels caused by a blood clot in an artery. Blocks in the femoral artery are particularly problematic, and vascular surgeons continue to research and debate on the best methods to treat these clots. Results from the THRUPASS Study Group’s randomized controlled trial comparing superficial femoral artery (SFA) lesion treatment with either endoluminal polytetrafluoroethylene (PTFE) thrupass (Viabahn) or with surgical PTFE bypass were presented to attendees at the 38th Annual VEITH symposium in New York City by Mauri J.A. Lepantalo, M.D., Helsinki University Central Hospital, Helsinki, Finland.

In the study, the SFA lesions of the patients were 5-25 cm occlusions, with a mean length of 11.4 cm. The patients were followed for three years by physical exam, duplex ultrasound or other imaging modalities. The endpoint of greatest interest was primary patency, followed by secondary patency, functional success, costs and quality of life. Lepantalo said, “The goal had been to enroll 60 patients in each arm. However, the trial was prematurely terminated due to results at the interim analysis, when only 44 patients had been enrolled. There was a significant patency difference in favor of surgical bypass over endovascular thrupass (95 percent versus 44 percent).”

Lepantalo noted that this was a difficult trial to enroll patients, because the investigators were looking carefully for comparable lesions to which to randomize treatment. “The real problem with comparing different modes of treatment for lower limb ischemia is in controlling for the disease, to ensure that the comparisons are among patients with the same lesions. This is compounded by the fact that different physicians interpreting the same lesions will characterize them differently,” said Lepantalo.

In this study, the results showed that treatment of superficial femoral artery occlusions should be done by PTFE bypass rather than by PTFE thrupass, as the later method leads to a worse early outcome.

For more information:

Related Content

Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery | September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
ClearFlow Inc. Announces Positive U.S. Clinical Trial Results
News | Cardiovascular Surgery | September 08, 2017
September 8, 2017 — ClearFlow Inc.
Videos | Cardiovascular Surgery | July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Intensive Glycemic Control Program Produces Significant Per-Patient Cost Savings for CABG Surgery
News | Cardiovascular Surgery | May 25, 2017
A new study from Emory University observed a near-20 percent reduction in perioperative complications, a 1.2-day...
Risk of Heart Transplant Rejection Reduced by Desensitizing Patient Antibodies
News | Cardiovascular Surgery | May 23, 2017
The risk of heart transplant rejection can be reduced by desensitizing patient antibodies, according to research...
Scientists Show How Cells React to Injury From Open-Heart Surgery
News | Cardiovascular Surgery | May 04, 2017
Cedars-Sinai Heart Institute investigators have learned how cardiac muscle cells react to a certain type of injury that...
ERACS Session Highlights Need for Standardized Best Practices in Cardiac Surgery
News | Cardiovascular Surgery | May 02, 2017
The recently formed group Enhanced Recovery After Cardiac Surgery (ERACS) hosted an organizing session in Boston on...
ClearFlow Receives Frost & Sullivan New Product Innovation Award for PleuraFlow Technology
News | Cardiovascular Surgery | May 01, 2017
ClearFlow Inc. has received the prestigious 2017 Global Frost & Sullivan Award for New Product Innovation. The...
Edwards Intuity Elite sutureless aortic valve, first implants in Connecticut, WCHN, Western Connecticut Health Network
News | Cardiovascular Surgery | February 16, 2017
Western Connecticut Health Network (WCHN) cardiothoracic surgeons Cary Passik, M.D., and Robert Gallagher, M.D., were...
open-heart surgery, PCI, percutaneous coronary intervention, NOBLE trial, left main coronary artery disease, LMCAD, TCT 2016
News | Cardiovascular Surgery | November 03, 2016
Coronary artery bypass (CABG) surgery is the standard treatment for revascularization in patients with left main...
Overlay Init